Prosecution Insights
Last updated: April 19, 2026

Examiner: MUMMERT, STEPHANIE KANE

Tech Center 1600 • Art Units: 1637 1681

This examiner grants 60% of resolved cases

Performance Statistics

60.5%
Allow Rate
+0.5% vs TC avg
788
Total Applications
+22.4%
Interview Lift
1457
Avg Prosecution Days
Based on 754 resolved cases, 2023–2026

Rejection Statute Breakdown

4.0%
§101 Eligibility
26.9%
§102 Novelty
46.0%
§103 Obviousness
10.5%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17048953 Compositions and Methods for Diagnosis and Treatment of Endometriosis Non-Final OA The Board of Regents of the University of Texas System
17677525 ANALYTICAL STANDARDS AND METHODS OF USING SAME Non-Final OA REGENTS OF THE UNIVERSITY OF MINNESOTA
18885063 METHODS FOR SIMULTANEOUS AMPLIFICATION OF TARGET LOCI Final Rejection Natera, Inc.
18812696 METHODS FOR SIMULTANEOUS AMPLIFICATION OF TARGET LOCI Non-Final OA Natera, Inc.
18733659 METHODS FOR SIMULTANEOUS AMPLIFICATION OF TARGET LOCI Final Rejection Natera, Inc.
17868141 METHODS FOR SIMULTANEOUS AMPLIFICATION OF TARGET LOCI Non-Final OA Natera, Inc.
16734814 METHODS FOR SIMULTANEOUS AMPLIFICATION OF TARGET LOCI Final Rejection Natera, Inc.
17646179 GENDER-SPECIFIC MARKERS FOR DIAGNOSING PROGNOSIS AND DETERMINING TREATMENT STRATEGY FOR RENAL CANCER PATIENTS Non-Final OA THE CATHOLIC UNIVERSITY OF KOREA INDUSTRY-ACADEMIC COOPERATION FOUNDATION
17574032 UNIVERSAL REPORTER-BASED GENOTYPING METHODS AND MATERIALS Non-Final OA LIFE TECHNOLOGIES CORPORATION
18105233 MOLECULAR BEACON BASED NANOPROBES FOR DIRECTLY DETECTING ORGAN-SPECIFIC MATASTASIS RELATED BIOMARKERS OF TUMOR CELLS IN PERIPHERAL BLOOD, PREPARATION METHOD AND APPLICATION Non-Final OA Wuhan University
17526743 SINGLE-STEP DNA PREPARATION FOR POLYMERASE CHAIN REACTION USING MAGNETIC CHITOSAN MICROPARTICLES Non-Final OA Canon U.S.A., Inc.
18045687 NUCLEIC ACID SEQUENCING METHODS AND SYSTEMS Non-Final OA Pacific Biosciences of California, Inc.
17498290 ISOLATION OF TARGET NUCLEIC ACIDS Non-Final OA Harbinger Health, Inc.
17845481 DETECTION OF COLORECTAL CANCER Non-Final OA Universal Diagnostics, S.A.
18119750 METHOD OF IDENTIFYING A PLURALITY OF MICROORGANISMS AND BIOMARKERS FOR ANTIBIOTIC RESISTANCE FROM A SAMPLE USING NUCLEICACID AMPLIFICATION TECHNOLOGY (NAT) Non-Final OA MANI M
17504903 SAMPLE PREPARATION FOR DIFFICULT SAMPLE TYPES Final Rejection BioFire Diagnostics, LLC

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month